A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease globally, and represents a health care burden as treatment options are very scarce. The reason behind the NAFLD progression to non-alcoholic steatohepatitis (NASH) is not completely understood. Recently, the deficiency o...

Full description

Bibliographic Details
Main Authors: Moris Sangineto, Vidyasagar Naik Bukke, Francesco Bellanti, Rosanna Tamborra, Archana Moola, Loren Duda, Rosanna Villani, Antonino Davide Romano, Gaetano Serviddio
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/13/2/652
_version_ 1797396277639512064
author Moris Sangineto
Vidyasagar Naik Bukke
Francesco Bellanti
Rosanna Tamborra
Archana Moola
Loren Duda
Rosanna Villani
Antonino Davide Romano
Gaetano Serviddio
author_facet Moris Sangineto
Vidyasagar Naik Bukke
Francesco Bellanti
Rosanna Tamborra
Archana Moola
Loren Duda
Rosanna Villani
Antonino Davide Romano
Gaetano Serviddio
author_sort Moris Sangineto
collection DOAJ
description Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease globally, and represents a health care burden as treatment options are very scarce. The reason behind the NAFLD progression to non-alcoholic steatohepatitis (NASH) is not completely understood. Recently, the deficiency of micronutrients (e.g., vitamins, minerals, and other elements) has been suggested as crucial in NAFLD progression, such that recent studies reported the potential hepatic antioxidant properties of micronutrients supplementation. However, very little is known. Here we have explored the potential beneficial effects of dietary supplementation with FLINAX, a novel mixture of nutraceuticals (i.e., vitamin E, vitamin D3, olive dry-extract, cinnamon dry-extract and fish oil) in a NAFLD model characterized by oxidative stress and mitochondrial function impairment. Steatosis was firstly induced in Wistar rats by feeding with a high-fat/high-cholesterol diet for 4 weeks, and following this the rats were divided into two groups. One group (n = 8) was treated for 2 weeks with a normal chow-diet, while a second group (n = 8) was fed with a chow-diet supplemented with 2% FLINAX. Along with the entire experiment (6 weeks), a third group of rats was fed with a chow-diet only as control. Statistical analysis was performed with Student’s T test or one-way ANOVA followed by post-hoc Bonferroni test when appropriate. Steatosis, oxidative stress and mitochondrial respiratory chain (RC) complexes activity were analyzed in liver tissues. The dietary supplementation with FLINAX significantly improved hepatic steatosis and lipid accumulation compared to untreated rats. The mRNA and protein levels analysis showed that <i>CPT1A</i> and <i>CPT2</i> were up-regulated by FLINAX, suggesting the enhancement of fatty acids oxidation (FAO). Important lipoperoxidation markers (i.e., HNE- and MDA-protein adducts) and the quantity of total mitochondrial oxidized proteins were significantly lower in FLINAX-treated rats. Intriguingly, FLINAX restored the mitochondrial function, stimulating the activity of mitochondrial RC complexes (i.e., I, II, III and ATP-synthase) and counteracting the peroxide production from pyruvate/malate (complex I) and succinate (complex II). Therefore, the supplementation with FLINAX reprogrammed the cellular energy homeostasis by restoring the efficiency of mitochondrial function, with a consequent improvement in steatosis.
first_indexed 2024-03-09T00:49:02Z
format Article
id doaj.art-d70507bf5cf34ef88f713245640e950f
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-09T00:49:02Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-d70507bf5cf34ef88f713245640e950f2023-12-11T17:21:36ZengMDPI AGNutrients2072-66432021-02-0113265210.3390/nu13020652A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD ModelMoris Sangineto0Vidyasagar Naik Bukke1Francesco Bellanti2Rosanna Tamborra3Archana Moola4Loren Duda5Rosanna Villani6Antonino Davide Romano7Gaetano Serviddio8C.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyC.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyInternal Medicine, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyC.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyC.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyPathology Unit, Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, ItalyC.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyC.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyC.U.R.E. (University Center for Liver Disease Research and Treatment), Liver Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, ItalyNon-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease globally, and represents a health care burden as treatment options are very scarce. The reason behind the NAFLD progression to non-alcoholic steatohepatitis (NASH) is not completely understood. Recently, the deficiency of micronutrients (e.g., vitamins, minerals, and other elements) has been suggested as crucial in NAFLD progression, such that recent studies reported the potential hepatic antioxidant properties of micronutrients supplementation. However, very little is known. Here we have explored the potential beneficial effects of dietary supplementation with FLINAX, a novel mixture of nutraceuticals (i.e., vitamin E, vitamin D3, olive dry-extract, cinnamon dry-extract and fish oil) in a NAFLD model characterized by oxidative stress and mitochondrial function impairment. Steatosis was firstly induced in Wistar rats by feeding with a high-fat/high-cholesterol diet for 4 weeks, and following this the rats were divided into two groups. One group (n = 8) was treated for 2 weeks with a normal chow-diet, while a second group (n = 8) was fed with a chow-diet supplemented with 2% FLINAX. Along with the entire experiment (6 weeks), a third group of rats was fed with a chow-diet only as control. Statistical analysis was performed with Student’s T test or one-way ANOVA followed by post-hoc Bonferroni test when appropriate. Steatosis, oxidative stress and mitochondrial respiratory chain (RC) complexes activity were analyzed in liver tissues. The dietary supplementation with FLINAX significantly improved hepatic steatosis and lipid accumulation compared to untreated rats. The mRNA and protein levels analysis showed that <i>CPT1A</i> and <i>CPT2</i> were up-regulated by FLINAX, suggesting the enhancement of fatty acids oxidation (FAO). Important lipoperoxidation markers (i.e., HNE- and MDA-protein adducts) and the quantity of total mitochondrial oxidized proteins were significantly lower in FLINAX-treated rats. Intriguingly, FLINAX restored the mitochondrial function, stimulating the activity of mitochondrial RC complexes (i.e., I, II, III and ATP-synthase) and counteracting the peroxide production from pyruvate/malate (complex I) and succinate (complex II). Therefore, the supplementation with FLINAX reprogrammed the cellular energy homeostasis by restoring the efficiency of mitochondrial function, with a consequent improvement in steatosis.https://www.mdpi.com/2072-6643/13/2/652non-alcoholic fatty liver diseasenutraceuticalmitochondriamicronutrientssteatosisoxidative stress
spellingShingle Moris Sangineto
Vidyasagar Naik Bukke
Francesco Bellanti
Rosanna Tamborra
Archana Moola
Loren Duda
Rosanna Villani
Antonino Davide Romano
Gaetano Serviddio
A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model
Nutrients
non-alcoholic fatty liver disease
nutraceutical
mitochondria
micronutrients
steatosis
oxidative stress
title A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model
title_full A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model
title_fullStr A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model
title_full_unstemmed A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model
title_short A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model
title_sort novel nutraceuticals mixture improves liver steatosis by preventing oxidative stress and mitochondrial dysfunction in a nafld model
topic non-alcoholic fatty liver disease
nutraceutical
mitochondria
micronutrients
steatosis
oxidative stress
url https://www.mdpi.com/2072-6643/13/2/652
work_keys_str_mv AT morissangineto anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT vidyasagarnaikbukke anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT francescobellanti anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT rosannatamborra anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT archanamoola anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT lorenduda anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT rosannavillani anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT antoninodavideromano anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT gaetanoserviddio anovelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT morissangineto novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT vidyasagarnaikbukke novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT francescobellanti novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT rosannatamborra novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT archanamoola novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT lorenduda novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT rosannavillani novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT antoninodavideromano novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel
AT gaetanoserviddio novelnutraceuticalsmixtureimprovesliversteatosisbypreventingoxidativestressandmitochondrialdysfunctioninanafldmodel